Prospective Cohort Study on Performance of Cerebrospinal Fluid (CSF) Xpert MTB/RIF, CSF Lipoarabinomannan (LAM) Lateral Flow Assay (LFA), and Urine LAM LFA for Diagnosis of Tuberculous Meningitis in Zambia
Author(s) -
Omar K. Siddiqi,
Gretchen L. Birbeck,
Musie Ghebremichael,
Eugene Mubanga,
Shawn Love,
Clayton Buback,
Barry Kosloff,
Helen Ayles,
Masharip Atadzhanov,
Keertan Dheda,
Igor J. Koralnik
Publication year - 2019
Publication title -
journal of clinical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.349
H-Index - 255
eISSN - 1070-633X
pISSN - 0095-1137
DOI - 10.1128/jcm.00652-19
Subject(s) - lipoarabinomannan , cerebrospinal fluid , tuberculous meningitis , medicine , meningitis , virology , urine , immunology , tuberculosis , pathology , mycobacterium tuberculosis , surgery
Tuberculous meningitis (TBM) is a devastating infection of the central nervous system lacking an adequate point-of-care diagnostic test. We conducted a prospective cohort study of 550 Zambian adults with suspected TBM to determine the diagnostic accuracy of cerebrospinal fluid (CSF) Xpert MTB/RIF, CSF lipoarabinomannan (LAM), urine LAM, CSF total protein, and CSF glucose compared with the gold standard of CSF culture.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom